共 28 条
[2]
The R144C change in the CYP2C9*2 allele alters interaction of the cytochrome P450 with NADPH:cytochrome P450 oxidoreductase
[J].
PHARMACOGENETICS,
1997, 7 (03)
:203-210
[6]
Genetic polymorphism of CYP2C9 and its effect on warfarin maintenance dose requirement in patients undergoing anticoagulation therapy
[J].
PHARMACOGENETICS,
1995, 5 (06)
:389-392
[8]
Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
2002, 287 (13)
:1690-1698
[9]
HIRSH J, 1995, CHEST S, V108, P231
[10]
HULL JH, 1978, CLIN PHARMACOL THER, V24, P644